                </a></li></ul></div><p><strong>Figure 6.  <span>The predicted binding of TP5 and its alanine substitutions to HLA-DR.</span></strong></p><a id="article1.body1.sec2.sec4.fig1.caption1.p1" name="article1.body1.sec2.sec4.fig1.caption1.p1"></a><p>The key residues (E11, N62) are in red; the other contacted residues are in orange. Peptide variants correspond to A: RKDVY; B: AKDVY; C: RADVY; D: RKAVY; E: RKDAY; F: RKDVA.</p>
